Seeking Alpha

Dan Rosenblum » Articles » VRUS |

  • Insider Buying in Biotech Land
    on Apr 01, 2008 • HGSI, MRBK, OMRI    
More on VRUS by Dan Rosenblum
Articles by Ticker

Latest Comments on Dan Rosenblum's Articles

  1. kastlem on ASCO: Whose Presentations Look the Most Promising?: Erbitux and Vectibix Grade 3 & 4 acneform rashes, and hypomagnemia... more »
  2. Agrippa on Why Sales Estimates for Dendreon's Provenge Are Too Low: Provenge demonstrated 4 months of survival benefit versus placebo... more »
  3. GotDOCG on Why Sales Estimates for Dendreon's Provenge Are Too Low: I pray that you are one of the 230,000 diagnosed with pc this...... more »
  4. GotDOCG on Why Sales Estimates for Dendreon's Provenge Are Too Low: True... relatively few ever use the treatment... and with surgery,... more »
  5. NYC-PC on Why Sales Estimates for Dendreon's Provenge Are Too Low: Michael, 33,000 patients/year out of 50-60,000 eligible is... more »
  6. Michael Murphy on Why Sales Estimates for Dendreon's Provenge Are Too Low: Dan - in my article on Dendreon at... more »
  7. Dan Rosenblum on Why Sales Estimates for Dendreon's Provenge Are Too Low: I agree with you on the pricing. I would like to see them price... more »
  8. NYC-PC on Why Sales Estimates for Dendreon's Provenge Are Too Low: I didn't quibble with your projection at all, just your 'facts'.... more »
  9. Dan Rosenblum on Why Sales Estimates for Dendreon's Provenge Are Too Low: For those of you who think I am way off base with my assumptions... more »
  10. quiact on Why Sales Estimates for Dendreon's Provenge Are Too Low: The price, comparitively speaking, may be appropriate. Look the... more »
  11. Jolly_Rancher on Why Sales Estimates for Dendreon's Provenge Are Too Low: I agree with you. $75,000 for 4 months doesn't look great compared... more »
  12. raytayzmd on Why Sales Estimates for Dendreon's Provenge Are Too Low: ...you should also bear in mind how provenge works...ultimately,... more »
  13. NYC-PC on Why Sales Estimates for Dendreon's Provenge Are Too Low: There are a number of errors in your column. 1st, the current... more »
  14. Robert0713 on Why Sales Estimates for Dendreon's Provenge Are Too Low: $4 billion per year to keep a handful of geezers alive for a... more »
  15. Dan Rosenblum on Why Sales Estimates for Dendreon's Provenge Are Too Low: I got the number of Hormone refractory failures from the company's... more »